We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$239M
AUM Growth
+$8.32M
Cap. Flow
-$5.16M
Cap. Flow %
-2.16%
Top 10 Hldgs %
35.11%
Holding
546
New
36
Increased
93
Reduced
108
Closed
33

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$3.15M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.48M
3
DLTR icon
Dollar Tree
DLTR
+$1.94M
4
VTV icon
Vanguard Morningstar Value ETF
VTV
+$857K
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$833K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.4M
2
EOG icon
EOG Resources
EOG
+$2.91M
3
UTHR icon
United Therapeutics
UTHR
+$2.5M
4
ZBRA icon
Zebra Technologies
ZBRA
+$1.98M
5
PVH icon
PVH
PVH
+$1.43M

Sector Composition

Rank Sector Weight
1 Financials 10.55%
2 Consumer Staples 7.28%
3 Technology 6.91%
4 Consumer Discretionary 6.75%
5 Industrials 6.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCTL
301
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$14K 0.01%
750
-86
-10% -$1.24K
DD
302
DELISTED
Du Pont De Nemours E I
DD
$14K 0.01%
213
– –
NLR icon
303
VanEck Uranium + Nuclear Energy ETF
NLR
$3.82B
$13K 0.01%
266
– –
NVDA icon
304
NVIDIA
NVDA
$4.86T
$13K 0.01%
2,200
– –
SOXX icon
305
iShares Semiconductor ETF
SOXX
$41.7B
$13K 0.01%
156
– –
TMV icon
306
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$187M
$13K 0.01%
456
– –
WEN icon
307
Wendy's
WEN
$1.4B
$13K 0.01%
583
– –
APTV icon
308
Aptiv
APTV
$12B
$12K 0.01%
130
– –
DB icon
309
Deutsche Bank
DB
$69B
$12K 0.01%
1,500
– –
DD icon
310
DuPont de Nemours
DD
$18.5B
$12K 0.01%
170
– –
F icon
311
Ford
F
$58.5B
$12K 0.01%
1,300
-300
-19% -$2.7K
FPE icon
312
First Trust Preferred Securities and Income ETF
FPE
$6.32B
$12K 0.01%
600
+400
+200% +$7.96K
FXO icon
313
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$12K 0.01%
350
– –
SWKS icon
314
Skyworks Solutions
SWKS
$9.37B
$12K 0.01%
102
– –
VRTX icon
315
Vertex Pharmaceuticals
VRTX
$121B
$12K 0.01%
55
+15
+38% +$3.04K
GDXJ icon
316
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$11K ﹤0.01%
250
– –
MCK icon
317
McKesson
MCK
$100B
$11K ﹤0.01%
83
– –
MDT icon
318
Medtronic
MDT
$109B
$11K ﹤0.01%
100
– –
DBGR
319
DELISTED
Xtrackers MSCI Germany Hedged Equity ETF
DBGR
$11K ﹤0.01%
400
– –
ACWV icon
320
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.32B
$10K ﹤0.01%
100
– –
COF icon
321
Capital One
COF
$128B
$10K ﹤0.01%
101
+1
+1% +$96
EOG icon
322
EOG Resources
EOG
$79.2B
$10K ﹤0.01%
114
-39,685
-100% -$2.91M
FREL icon
323
Fidelity MSCI Real Estate Index ETF
FREL
$1.5B
$10K ﹤0.01%
+350
New +$9.7K
HYLS icon
324
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.61B
$10K ﹤0.01%
200
– –
MCHP icon
325
Microchip Technology
MCHP
$40.3B
$10K ﹤0.01%
200
– –
11 12
13
14 15

Similar funds

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
LHR
Lunate Holding RSC Al Maryah Island, Abu Dhabi, United Arab Emirates $211M AUM
HPFG
Hart & Patterson Financial Group Amherst, Massachusetts $206M AUM 7.82% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
KC
Kades & Cheifetz Berwyn, Pennsylvania $195M AUM 11.87% 1-Year Est. Return
SL
SIB LLC New York, New York $190M AUM 9.27% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return

AlphaMark Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, AlphaMark Advisors held 546 positions worth $239M, up 3.6% from $231M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

AlphaMark Advisors's Q4 2019 filing shows 36 new, 93 increased, 108 reduced and 33 closed positions. Its largest new stake was Alexion Pharmaceuticals: 29,481 shares worth $3.19M. The largest sale was Celgene Corp, an estimated $4.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 10% a quarter earlier, followed by Consumer Staples and Technology.

  • AlphaMark Advisors's largest Q4 2019 buy was Alexion Pharmaceuticals: 29,481 shares worth $3.19M.
  • AlphaMark Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.48M increase.
  • AlphaMark Advisors's biggest Q4 2019 reduction was EOG Resources, cutting an estimated $2.91M.
  • AlphaMark Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $4.4M.
  • AlphaMark Advisors's ten largest holdings make up 35% of its $239M portfolio in Q4 2019.
  • AlphaMark Advisors opened 36 new positions and closed 33 in Q4 2019.
  • AlphaMark Advisors's portfolio value rose 3.6% quarter-over-quarter to $239M.

Based on AlphaMark Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.